Original Research15 August 2017
A Multinational Cohort Study
    Author, Article, and Disclosure Information



    The relationship between coffee consumption and mortality in diverse European populations with variable coffee preparation methods is unclear.


    To examine whether coffee consumption is associated with all-cause and cause-specific mortality.


    Prospective cohort study.


    10 European countries.


    521 330 persons enrolled in EPIC (European Prospective Investigation into Cancer and Nutrition).


    Hazard ratios (HRs) and 95% CIs estimated using multivariable Cox proportional hazards models. The association of coffee consumption with serum biomarkers of liver function, inflammation, and metabolic health was evaluated in the EPIC Biomarkers subcohort (n = 14 800).


    During a mean follow-up of 16.4 years, 41 693 deaths occurred. Compared with nonconsumers, participants in the highest quartile of coffee consumption had statistically significantly lower all-cause mortality (men: HR, 0.88 [95% CI, 0.82 to 0.95]; P for trend < 0.001; women: HR, 0.93 [CI, 0.87 to 0.98]; P for trend = 0.009). Inverse associations were also observed for digestive disease mortality for men (HR, 0.41 [CI, 0.32 to 0.54]; P for trend < 0.001) and women (HR, 0.60 [CI, 0.46 to 0.78]; P for trend < 0.001). Among women, there was a statistically significant inverse association of coffee drinking with circulatory disease mortality (HR, 0.78 [CI, 0.68 to 0.90]; P for trend < 0.001) and cerebrovascular disease mortality (HR, 0.70 [CI, 0.55 to 0.90]; P for trend = 0.002) and a positive association with ovarian cancer mortality (HR, 1.31 [CI, 1.07 to 1.61]; P for trend = 0.015). In the EPIC Biomarkers subcohort, higher coffee consumption was associated with lower serum alkaline phosphatase; alanine aminotransferase; aspartate aminotransferase; γ-glutamyltransferase; and, in women, C-reactive protein, lipoprotein(a), and glycated hemoglobin levels.


    Reverse causality may have biased the findings; however, results did not differ after exclusion of participants who died within 8 years of baseline. Coffee-drinking habits were assessed only once.


    Coffee drinking was associated with reduced risk for death from various causes. This relationship did not vary by country.

    Primary Funding Source:

    European Commission Directorate-General for Health and Consumers and International Agency for Research on Cancer.


    • 1. Gómez-Ruiz JALeake DSAmes JMIn vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem2007;55:6962-9. [PMID: 17655324] CrossrefMedlineGoogle Scholar
    • 2. Lopez-Garcia Evan Dam RMQi LHu FBCoffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr2006;84:888-93. [PMID: 17023717] CrossrefMedlineGoogle Scholar
    • 3. Wedick NMBrennan AMSun QHu FBMantzoros CSvan Dam RMEffects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J2011;10:93. [PMID: 21914162] doi:10.1186/1475-2891-10-93 CrossrefMedlineGoogle Scholar
    • 4. Loopstra-Masters RCLiese ADHaffner SMWagenknecht LEHanley AJAssociations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia2011;54:320-8. [PMID: 21046357] doi:10.1007/s00125-010-1957-8 CrossrefMedlineGoogle Scholar
    • 5. van Dam RMCoffee and type 2 diabetes: from beans to beta-cells. Nutr Metab Cardiovasc Dis2006;16:69-77. [PMID: 16399494] CrossrefMedlineGoogle Scholar
    • 6. van Dam RMWillett WCManson JEHu FBCoffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care2006;29:398-403. [PMID: 16443894] CrossrefMedlineGoogle Scholar
    • 7. Lindsted KDKuzma JWAnderson JLCoffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol1992;45:733-42. [PMID: 1619453] CrossrefMedlineGoogle Scholar
    • 8. Andersen LFJacobs DRCarlsen MHBlomhoff RConsumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr2006;83:1039-46. [PMID: 16685044] CrossrefMedlineGoogle Scholar
    • 9. Woodward MTunstall-Pedoe HCoffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health1999;53:481-7. [PMID: 10562866] CrossrefMedlineGoogle Scholar
    • 10. Freedman NDPark YAbnet CCHollenbeck ARSinha RAssociation of coffee drinking with total and cause-specific mortality. N Engl J Med2012;366:1891-904. [PMID: 22591295] doi:10.1056/NEJMoa1112010 CrossrefMedlineGoogle Scholar
    • 11. Ding MSatija ABhupathiraju SNHu YSun QHan Jet alAssociation of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation2015;132:2305-15. [PMID: 26572796] doi:10.1161/CIRCULATIONAHA.115.017341 CrossrefMedlineGoogle Scholar
    • 12. Loftfield EFreedman NDGraubard BIGuertin KABlack AHuang WYet alAssociation of coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am J Epidemiol2015;182:1010-22. [PMID: 26614599] doi:10.1093/aje/kwv146 CrossrefMedlineGoogle Scholar
    • 13. Tverdal AStensvold ISolvoll KFoss OPLund-Larsen PBjartveit KCoffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ1990;300:566-9. [PMID: 2108750] CrossrefMedlineGoogle Scholar
    • 14. Rosengren AWilhelmsen LCoffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med1991;230:67-71. [PMID: 2066712] CrossrefMedlineGoogle Scholar
    • 15. Lopez-Garcia Evan Dam RMLi TYRodriguez-Artalejo FHu FBThe relationship of coffee consumption with mortality. Ann Intern Med2008;148:904-14. [PMID: 18559841]. doi:10.7326/0003-4819-148-12-200806170-00003 LinkGoogle Scholar
    • 16. Sugiyama KKuriyama SAkhter MKakizaki MNakaya NOhmori-Matsuda Ket alCoffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr2010;140:1007-13. [PMID: 20335629] doi:10.3945/jn.109.109314 CrossrefMedlineGoogle Scholar
    • 17. Crippa ADiscacciati ALarsson SCWolk AOrsini NCoffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol2014;180:763-75. [PMID: 25156996] doi:10.1093/aje/kwu194 CrossrefMedlineGoogle Scholar
    • 18. Riboli EKaaks RThe EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol1997;26 Suppl 1:S6-14. [PMID: 9126529] MedlineGoogle Scholar
    • 19. Riboli EHunt KJSlimani NFerrari PNorat TFahey Met alEuropean Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr2002;5:1113-24. [PMID: 12639222] CrossrefMedlineGoogle Scholar
    • 20. Greenland SLongnecker MPMethods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol1992;135:1301-9. [PMID: 1626547] CrossrefMedlineGoogle Scholar
    • 21. Ding PVanderWeele TJSensitivity analysis without assumptions. Epidemiology2016;27:368-77. [PMID: 26841057] doi:10.1097/EDE.0000000000000457 CrossrefMedlineGoogle Scholar
    • 22. Royston PParmar MKFlexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med2002;21:2175-97. [PMID: 12210632] CrossrefMedlineGoogle Scholar
    • 23. Office for National Statistics. Revised European Standard Population 2013 (2013 ESP). 2017. Accessed at www.ons.gov.uk/ons/guide-method/user-guidance/health-and-life-events/revised-european-standard-population-2013–2013-esp-/index.html on 1 April 2017. Google Scholar
    • 24. Tamakoshi ALin YKawado MYagyu KKikuchi SIso HJACC Study GroupEffect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol2011;26:285-93. [PMID: 21298466] doi:10.1007/s10654-011-9548-7 CrossrefMedlineGoogle Scholar
    • 25. Klatsky ALMorton CUdaltsova NFriedman GDCoffee, cirrhosis, and transaminase enzymes. Arch Intern Med2006;166:1190-5. [PMID: 16772246] CrossrefMedlineGoogle Scholar
    • 26. Tverdal ASkurtveit SCoffee intake and mortality from liver cirrhosis. Ann Epidemiol2003;13:419-23. [PMID: 12875799] CrossrefMedlineGoogle Scholar
    • 27. Corrao GZambon ABagnardi VD'Amicis AKlatsky ACollaborative SIDECIR GroupCoffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol2001;11:458-65. [PMID: 11557177] CrossrefMedlineGoogle Scholar
    • 28. Casiglia ESpolaore PGinocchio GAmbrosio GBUnexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol1993;9:293-7. [PMID: 8104822] CrossrefMedlineGoogle Scholar
    • 29. Saab SMallam DCox GATong MJImpact of coffee on liver diseases: a systematic review. Liver Int2014;34:495-504. [PMID: 24102757] doi:10.1111/liv.12304 CrossrefMedlineGoogle Scholar
    • 30. Gressner OALahme BRehbein KSiluschek MWeiskirchen RGressner AMPharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol2008;49:758-67. [PMID: 18486259] doi:10.1016/j.jhep.2008.03.029 CrossrefMedlineGoogle Scholar
    • 31. Shim SGJun DWKim EKSaeed WKLee KNLee HLet alCaffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol2013;28:1877-84. [PMID: 23808892] doi:10.1111/jgh.12317 CrossrefMedlineGoogle Scholar
    • 32. Vitaglione PMorisco FMazzone GAmoruso DCRibecco MTRomano Aet alCoffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology2010;52:1652-61. [PMID: 21038411] doi:10.1002/hep.23902 CrossrefMedlineGoogle Scholar
    • 33. Freedman NDEverhart JELindsay KLGhany MGCurto TMShiffman MLet alHALT-C Trial GroupCoffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology2009;50:1360-9. [PMID: 19676128] doi:10.1002/hep.23162 CrossrefMedlineGoogle Scholar
    • 34. Larsson SCVirtamo JWolk ACoffee consumption and risk of stroke in women. Stroke2011;42:908-12. [PMID: 21393590] doi:10.1161/STROKEAHA.110.603787 CrossrefMedlineGoogle Scholar
    • 35. Lopez-Garcia ERodriguez-Artalejo FRexrode KMLogroscino GHu FBvan Dam RMCoffee consumption and risk of stroke in women. Circulation2009;119:1116-23. [PMID: 19221216] doi:10.1161/CIRCULATIONAHA.108.826164 CrossrefMedlineGoogle Scholar
    • 36. Di Angelantonio ESarwar NPerry PKaptoge SRay KKThompson Aet alEmerging Risk Factors CollaborationMajor lipids, apolipoproteins, and risk of vascular disease. JAMA2009;302:1993-2000. [PMID: 19903920] doi:10.1001/jama.2009.1619 CrossrefMedlineGoogle Scholar
    • 37. Smolders BLemmens RThijs VLipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke2007;38:1959-66. [PMID: 17478739] CrossrefMedlineGoogle Scholar
    • 38. Rost NSWolf PAKase CSKelly-Hayes MSilbershatz HMassaro JMet alPlasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke2001;32:2575-9. [PMID: 11692019] CrossrefMedlineGoogle Scholar
    • 39. Ridker PMHennekens CHBuring JERifai NC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med2000;342:836-43. [PMID: 10733371] CrossrefMedlineGoogle Scholar
    • 40. Khaw KTWareham NGlycated hemoglobin as a marker of cardiovascular risk. Curr Opin Lipidol2006;17:637-43. [PMID: 17095908] CrossrefMedlineGoogle Scholar
    • 41. Lueth NAAnderson KEHarnack LJFulkerson JARobien KCoffee and caffeine intake and the risk of ovarian cancer: the Iowa Women's Health Study. Cancer Causes Control2008;19:1365-72. [PMID: 18704717] doi:10.1007/s10552-008-9208-8 CrossrefMedlineGoogle Scholar
    • 42. Braem MGOnland-Moret NCSchouten LJTjønneland AHansen LDahm CCet alCoffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr2012;95:1172-81. [PMID: 22440851] doi:10.3945/ajcn.111.026393 CrossrefMedlineGoogle Scholar
    • 43. Tworoger SSGertig DMGates MAHecht JLHankinson SECaffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer2008;112:1169-77. [PMID: 18213613] doi:10.1002/cncr.23275 CrossrefMedlineGoogle Scholar
    • 44. Lucas MO'Reilly EJPan AMirzaei FWillett WCOkereke OIet alCoffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry2014;15:377-86. [PMID: 23819683] doi:10.3109/15622975.2013.795243 CrossrefMedlineGoogle Scholar
    • 45. Tanskanen ATuomilehto JViinamäki HVartiainen ELehtonen JPuska PHeavy coffee drinking and the risk of suicide. Eur J Epidemiol2000;16:789-91. [PMID: 11297219] CrossrefMedlineGoogle Scholar